Lexaria Days Sales Outstanding from 2010 to 2024

LEXXW Stock  USD 0.75  0.04  5.63%   
Lexaria Bioscience Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding will likely drop to 26.35 in 2024. During the period from 2010 to 2024, Lexaria Bioscience Days Sales Outstanding regression line of quarterly data had mean square error of  41,953 and geometric mean of  345.27. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
121.44470554
Current Value
26.34659735
Quarterly Volatility
336.25573897
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 K, Interest Expense of 125.2 K or Other Operating Expenses of 3.2 M, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 54.87. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Lexaria Bioscience Corp over the last few years. It is Lexaria Bioscience's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Lexaria Days Sales Outstanding Regression Statistics

Arithmetic Mean479.46
Geometric Mean345.27
Coefficient Of Variation70.13
Mean Deviation292.51
Median297.97
Standard Deviation336.26
Sample Variance113,068
Range1.1K
R-Value(0.81)
Mean Square Error41,953
R-Squared0.66
Significance0.0003
Slope(60.87)
Total Sum of Squares1.6M

Lexaria Days Sales Outstanding History

2024 26.35
2023 121.44
2022 282.77
2021 288.38
2020 172.92
2019 297.97
2018 447.86

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 121.44  26.35 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.